Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq touch new peaks as Treasury yields cool, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| (NASDAQ: BMEA) | Delayed: 1.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.30 | 52 Week High | $ | |||
| Open | $1.28 | 52 Week Low | $ | |||
| Day High | $1.31 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $ | |||
| Volume | 246,791 | |||||
